<HashMap><database>MetabolomicsWorkbench</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>http://www.metabolomicsworkbench.org/rest/study/study_id/ST000320/mwtab</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Metabolomics</omics_type><technology_type>Mass Spectrometry</technology_type><technology_type>ESI</technology_type><species>Arabidopsis Thaliana</species><full_dataset_link>http://www.metabolomicsworkbench.org/data/DRCCMetadata.php?Mode=Study&amp;StudyID=ST000320</full_dataset_link><study_factor>Treatment:Control</study_factor><study_factor>Treatment:133</study_factor><study_factor>Treatment:111</study_factor><tissue>Seeds</tissue><submitter_affiliation>University of California, Davis</submitter_affiliation><sample_protocol>Reversed phase POSITIVE ION MODE. Reversed phase NEGATIVE ION MODE.</sample_protocol><repository>MetabolomicsWorkbench</repository><metabolite_name>TG (56:3)</metabolite_name><metabolite_name>TG (53:4)</metabolite_name><metabolite_name>TG (55:2)</metabolite_name><metabolite_name>TG (58:3)</metabolite_name><metabolite_name>TG (56:7)</metabolite_name><metabolite_name>TG (52:5)</metabolite_name><metabolite_name>TG (54:7)</metabolite_name><metabolite_name>TG (56:5)</metabolite_name><metabolite_name>TG (50:5)</metabolite_name><metabolite_name>TG (51:4)</metabolite_name><metabolite_name>CE (20:3)</metabolite_name><metabolite_name>PC (34:4)</metabolite_name><metabolite_name>DG (36:4)_2</metabolite_name><metabolite_name>DG (36:4)_1</metabolite_name><metabolite_name>PE (36:2)</metabolite_name><metabolite_name>LPC (18:3)</metabolite_name><metabolite_name>PG (34:2)</metabolite_name><metabolite_name>PE (34:2)</metabolite_name><metabolite_name>TG (53:5)</metabolite_name><metabolite_name>TG (54:4)</metabolite_name><metabolite_name>TG (55:1)</metabolite_name><metabolite_name>TG (54:2)</metabolite_name><metabolite_name>TG (56:6)</metabolite_name><metabolite_name>TG (52:4)</metabolite_name><metabolite_name>TG (54:8)</metabolite_name><metabolite_name>TG (58:2)</metabolite_name><metabolite_name>TG (56:4)</metabolite_name><metabolite_name>TG (52:6)</metabolite_name><metabolite_name>TG (54:6)</metabolite_name><metabolite_name>TG (58:4)</metabolite_name><metabolite_name>TG (50:4)</metabolite_name><metabolite_name>GlcCer(d14:1(4E)/20:0(2OH))</metabolite_name><metabolite_name>PE (34:1)</metabolite_name><metabolite_name>DG (36:3)</metabolite_name><metabolite_name>PC (36:5)</metabolite_name><metabolite_name>DG (38:3)</metabolite_name><metabolite_name>PC (34:3)</metabolite_name><metabolite_name>PE (36:3)</metabolite_name><metabolite_name>PE (34:3)</metabolite_name><metabolite_name>TG (58:6)</metabolite_name><metabolite_name>TG (56:8)</metabolite_name><data_protocol></data_protocol><name_synonyms>imprinted and ancient gene protein, treatment, Therapy, Materials, Genetic, Cresses, A., Arabidopsis thaliana, Mouse-ear Cress, thaliana, Gene, INSDC_feature:gene, A. thaliana, Mouse-ear Cresses, Cistrons, Ximpact, Treatments, impact-a, Mouse-ear, Arabidopsis, Arabidopsis thalianas, Therapeutic, Material, A. thalianas, disease management, Therapies, thalianas, Genetic Materials, imprinted and ancient gene protein homolog, IMPACT, Treatment, Cistron, Cress, Mouse ear, E430016J11Rik, Arabidopses, Genetic Material, RWDD5, Cardaminopsis.</name_synonyms><sample_synonyms>backward, reversed., reversed</sample_synonyms></additional><is_claimable>false</is_claimable><name>Single treatment gene impact on Arabidopsis metabolites</name><description/><dates><publication></publication></dates><accession>ST000320</accession><cross_references><TAXONOMY>3702</TAXONOMY></cross_references></HashMap>